The hypothesis that a single complex (ERCC1/XPF) and/or DNA pol β could be associated with platinum response can be viewed as simplistic and, as discussed above, other factors (i.e., HR proficiency, tumor heterogeneity) could play a more important role in platinum sensitivity/resistance. The gene discussed is ERCC4; the disease is neoplasm.